IL33 (Interleukin-33) variants and mutations
IL33 (also known as Interleukin-33) is a human protein-coding gene encoding an interleukin-33 protein. It acts as an epithelial and stromal alarm signal released during tissue stress, activating type 2 immune responses through ST2-expressing cells. Excess IL-33 signaling contributes to asthma, allergy, and other inflammatory diseases. This analysis covers 583 IL33 variants and mutations. Of these, 85% have computational variant effect predictions. Disease context includes asthma, allergic disease, and allergic rhinitis. Example IL33 variants include K2*, K2N, and K2R.
Variant analysis overview
- Gene: IL33
- Protein: Interleukin-33
- UniProt accession: O95760
- Organism: Homo sapiens
- Variants analyzed: 583
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 364 unspecified-consequence records; 108 missense variants; 82 synonymous variants; 13 frameshift variants; 13 stop-gained variants; 2 in-frame insertions; 2 splice-region variants; 1 in-frame deletions
- Prediction scores: 496 variants have prediction scores (85% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: asthma, allergic disease, allergic rhinitis, respiratory system disorder, Wheezing, childhood onset asthma, chronic rhinosinusitis with nasal polyps, deep vein thrombosis, chronic rhinosinusitis, nasal cavity polyp, atopic IgE-mediated allergic disorder, sinusitis.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable IL33 variants
Examples include K2*, K2N, K2R, P3A, P3T, P3L, P3P, K4E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- K2* (p.Lys2Ter), Ensembl rs1819536977
- K2N (p.Lys2Asn), TOPMed rs1422033408, gnomAD rs1422033408, AlphaMissense 0.39, MetaLR 0.24
- K2R (p.Lys2Arg), gnomAD 9-6241699-A-G, AlphaMissense 0.11, MetaLR 0.06
- P3A (p.Pro3Ala), gnomAD rs1819537567, AlphaMissense 0.11, MetaLR 0.14
- P3T (p.Pro3Thr), gnomAD 9-6241701-C-A, AlphaMissense 0.11, MetaLR 0.18
- P3L (p.Pro3Leu), gnomAD 9-6241702-C-T, AlphaMissense 0.23, MetaLR 0.22
- P3P (p.Pro3Pro), gnomAD 9-6241703-T-C, CADD 7.87
- K4E (p.Lys4Glu), rs754773206, ClinGen CA4978697, ClinVar RCV004237667, ExAC rs754773206, AlphaMissense 0.12, MetaLR 0.06, Uncertain significance, not specified
- K4T (p.Lys4Thr), 1000Genomes rs566807686, ExAC rs566807686, TOPMed rs566807686, gnomAD rs566807686, AlphaMissense 0.14, MetaLR 0.15, Uncertain significance, not specified
- K4K (p.Lys4Lys), rs1368380523, gnomAD 9-6241706-A-G, CADD 9.71
- M5I (p.Met5Ile), cosmic curated COSV10891, Ensembl rs2130320924, AlphaMissense 0.39, MetaLR 0.16
- M5R (p.Met5Arg), ExAC rs771108276, gnomAD rs771108276, AlphaMissense 0.19, MetaLR 0.12
- M5V (p.Met5Val), ExAC rs747277388, TOPMed rs747277388, gnomAD rs747277388, AlphaMissense 0.12, MetaLR 0.09
- M5* (p.Met5Ter), gnomAD 9-6241703-TA-T, CADD 18.50
- K6Q (p.Lys6Gln), TOPMed rs1819538412
- K6K (p.Lys6Lys), rs776881287, gnomAD 9-6241712-G-A, CADD 9.17
- Y7C (p.Tyr7Cys), gnomAD 9-6241714-A-G, AlphaMissense 0.15, MetaLR 0.13
- T9N (p.Thr9Asn), gnomAD rs1344341471
- T9A (p.Thr9Ala), gnomAD 9-6241719-A-G, AlphaMissense 0.08, MetaLR 0.09
- T9I (p.Thr9Ile), gnomAD 9-6241720-C-T, AlphaMissense 0.26, MetaLR 0.18
- T9S (p.Thr9Ser), gnomAD 9-6241720-C-G, AlphaMissense 0.12, MetaLR 0.08
- T9T (p.Thr9Thr), rs746002088, gnomAD 9-6241721-C-T, CADD 7.55
- N10K (p.Asn10Lys), gnomAD 9-6241724-C-A, AlphaMissense 0.12, MetaLR 0.07
- N10N (p.Asn10Asn), rs1819539017, gnomAD 9-6241724-C-T, CADD 7.36
- K11E (p.Lys11Glu), cosmic curated COSV67343, TOPMed rs1819539160, AlphaMissense 0.12, MetaLR 0.11
- K11I (p.Lys11Ile), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10119, Variant assessed as somatic; moderate impact.
- K11N (p.Lys11Asn), rs769902678, NCI-TCGA Cosmic COSV1011, cosmic curated COSV10119, ExAC rs769902678, AlphaMissense 0.24, MetaLR 0.16, Variant assessed as somatic; moderate impact.
- I12V (p.Ile12Val), gnomAD 9-6241728-A-G, AlphaMissense 0.10, MetaLR 0.12
- I12T (p.Ile12Thr), gnomAD 9-6241729-T-C, AlphaMissense 0.18, MetaLR 0.10
- I12I (p.Ile12Ile), gnomAD 9-6241730-T-A, CADD 2.45
- S13F (p.Ser13Phe), NCI-TCGA Cosmic COSV6734, cosmic curated COSV67342, AlphaMissense 0.18, MetaLR 0.28, Variant assessed as somatic; moderate impact.
- S13S (p.Ser13Ser), gnomAD 9-6241733-C-T, CADD 4.54
- T14A (p.Thr14Ala), gnomAD rs1819539566, AlphaMissense 0.07, MetaLR 0.08
- T14I (p.Thr14Ile), Ensembl rs1819539692, AlphaMissense 0.14, MetaLR 0.09
- T14T (p.Thr14Thr), gnomAD 9-6241736-A-G, CADD 1.65
- A15S (p.Ala15Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A15T (p.Ala15Thr), rs865842230, ClinGen CA188630783, ClinVar RCV004228445, TOPMed rs865842230, AlphaMissense 0.10, MetaLR 0.30, Uncertain significance, not specified
- A15A (p.Ala15Ala), gnomAD 9-6241739-A-G, CADD 2.40
- K16N (p.Lys16Asn), gnomAD rs940371326
- K16R (p.Lys16Arg), rs1213823321, ClinGen CA372918249, ClinVar RCV004405268, gnomAD rs1213823321, AlphaMissense 0.09, MetaLR 0.14, Uncertain significance, not specified
- K16K (p.Lys16Lys), rs940371326, gnomAD 9-6241742-G-A, CADD 0.98
- W17* (p.Trp17Ter), ExAC rs776153612, gnomAD rs776153612, NCI-TCGA TCGA novel, CADD 0.16, Variant assessed as somatic; high impact.
- W17C (p.Trp17Cys), ExAC rs763483741, TOPMed rs763483741, gnomAD rs763483741, AlphaMissense 0.17, MetaLR 0.05
- W17L (p.Trp17Leu), gnomAD 9-6241744-G-T, AlphaMissense 0.08, MetaLR 0.03
- K18K (p.Lys18Lys), rs764581404, gnomAD 9-6241748-G-A, CADD 1.66
- N19D (p.Asn19Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N19S (p.Asn19Ser), ESP rs372934238, ExAC rs372934238, TOPMed rs372934238, gnomAD rs372934238, AlphaMissense 0.10, MetaLR 0.02
- N19N (p.Asn19Asn), gnomAD 9-6241751-C-T, CADD 0.84
- A21V (p.Ala21Val), gnomAD 9-6241756-C-T, AlphaMissense 0.16, MetaLR 0.16
- S22G (p.Ser22Gly), Ensembl rs760892788, AlphaMissense 0.07, MetaLR 0.03
- S22R (p.Ser22Arg), TOPMed rs1219952994, gnomAD rs1219952994, AlphaMissense 0.25, MetaLR 0.07
- K23T (p.Lys23Thr), TOPMed rs1819541255
- K23R (p.Lys23Arg), gnomAD 9-6241762-A-G, AlphaMissense 0.09, MetaLR 0.09
- A24D (p.Ala24Asp), ExAC rs767146393, TOPMed rs767146393, gnomAD rs767146393, AlphaMissense 0.23, MetaLR 0.19
- A24T (p.Ala24Thr), ExAC rs762211104, gnomAD rs762211104, AlphaMissense 0.12, MetaLR 0.12
- A24G (p.Ala24Gly), gnomAD 9-6241765-C-G, AlphaMissense 0.13, MetaLR 0.14
- A24V (p.Ala24Val), gnomAD 9-6241765-C-T, AlphaMissense 0.17, MetaLR 0.11
- A24A (p.Ala24Ala), rs557833104, gnomAD 9-6241766-C-T, CADD 1.44
- L25F (p.Leu25Phe), NCI-TCGA TCGA novel, AlphaMissense 0.09, MetaLR 0.26, Variant assessed as somatic; moderate impact.
- L25L (p.Leu25Leu), gnomAD 9-6241767-T-C, CADD 0.31
- L25S (p.Leu25Ser), gnomAD 9-6241768-T-C, AlphaMissense 0.15, MetaLR 0.13
- C26* (p.Cys26Ter), ExAC rs765810637, gnomAD rs765810637, CADD 31.00
- C26F (p.Cys26Phe), ExAC rs755596629, gnomAD rs755596629, AlphaMissense 0.17, MetaLR 0.07, Uncertain significance, not specified
- C26S (p.Cys26Ser), TOPMed rs1819542392, AlphaMissense 0.19, MetaLR 0.07
- C26C (p.Cys26Cys), gnomAD 9-6241772-T-C, CADD 3.34
- F27L (p.Phe27Leu), gnomAD 9-6241775-C-G, AlphaMissense 0.60, MetaLR 0.08
- K28N (p.Lys28Asn), ExAC rs754861043, TOPMed rs754861043, gnomAD rs754861043, AlphaMissense 0.36, MetaLR 0.18, Uncertain significance, not specified
- K28Q (p.Lys28Gln), ExAC rs753806663, TOPMed rs753806663, gnomAD rs753806663, AlphaMissense 0.15, MetaLR 0.30
- K28R (p.Lys28Arg), gnomAD 9-6241777-A-G, AlphaMissense 0.10, MetaLR 0.14
- L29M (p.Leu29Met), TOPMed rs1161011437, AlphaMissense 0.11, MetaLR 0.20
- L29L (p.Leu29Leu), rs1161011437, gnomAD 9-6241779-C-T, CADD 0.88
- L29R (p.Leu29Arg), rs1564063799, gnomAD 9-6241779-CT-C, CADD 14.10
- L29P (p.Leu29Pro), gnomAD 9-6241780-T-C, AlphaMissense 0.11, MetaLR 0.14
- G30E (p.Gly30Glu), rs778800068, NCI-TCGA TCGA novel, NCI-TCGA Cosmic COSV6734, cosmic curated COSV67342, AlphaMissense 0.12, MetaLR 0.05, Variant assessed as somatic; high impact.
- G30R (p.Gly30Arg), TOPMed rs1819543593, gnomAD rs1819543593, AlphaMissense 0.15, MetaLR 0.04
- G30V (p.Gly30Val), gnomAD 9-6241783-G-T, AlphaMissense 0.18, MetaLR 0.05
- K31E (p.Lys31Glu), 1000Genomes rs533535426, ExAC rs533535426, TOPMed rs533535426, gnomAD rs533535426, AlphaMissense 0.11, MetaLR 0.04
- K31N (p.Lys31Asn), gnomAD rs1816283684, AlphaMissense 0.22, MetaLR 0.22
- S32C (p.Ser32Cys), ExAC rs750639062, TOPMed rs750639062, gnomAD rs750639062, AlphaMissense 0.11, MetaLR 0.15
- Q33H (p.Gln33His), ExAC rs756352838, gnomAD rs756352838, AlphaMissense 0.20, MetaLR 0.23
- Q33Q (p.Gln33Gln), rs756352838, gnomAD 9-6250481-A-G, CADD 3.48
- Q34H (p.Gln34His), TOPMed rs1306430000, gnomAD rs1306430000, AlphaMissense 0.28, MetaLR 0.26
- Q34K (p.Gln34Lys), cosmic curated COSV67342, gnomAD rs1156818622, AlphaMissense 0.09, MetaLR 0.14
- Q34R (p.Gln34Arg), TOPMed rs1816284857
- Q34* (p.Gln34Ter), gnomAD 9-6250482-C-T, CADD 35.00
- K35N (p.Lys35Asn), gnomAD rs1431416448, AlphaMissense 0.26, MetaLR 0.17
- K35R (p.Lys35Arg), Ensembl rs2130418759, AlphaMissense 0.11, MetaLR 0.22
- A36A (p.Ala36Ala), gnomAD 9-6250490-C-G, CADD 0.15
- K37R (p.Lys37Arg), gnomAD 9-6250492-A-G, AlphaMissense 0.09, MetaLR 0.10
- E38* (p.Glu38Ter), NCI-TCGA Cosmic COSV6734, cosmic curated COSV67342, Variant assessed as somatic; high impact.
- E38K (p.Glu38Lys), gnomAD 9-6250490-CA-C, CADD 13.40
- E38D (p.Glu38Asp), gnomAD 9-6250496-A-T, AlphaMissense 0.13, MetaLR 0.11
- V39F (p.Val39Phe), 1000Genomes rs181411126, ExAC rs181411126, TOPMed rs181411126, gnomAD rs181411126, AlphaMissense 0.11, MetaLR 0.11
- V39I (p.Val39Ile), 1000Genomes rs181411126, ExAC rs181411126, TOPMed rs181411126, gnomAD rs181411126, AlphaMissense 0.09, MetaLR 0.10
- V39V (p.Val39Val), gnomAD 9-6250499-T-A, CADD 0.32
- C40S (p.Cys40Ser), 1000Genomes rs185775049, gnomAD rs185775049, AlphaMissense 0.27, MetaLR 0.16
- C40* (p.Cys40Ter), gnomAD 9-6250502-C-A, CADD 32.00
- C40C (p.Cys40Cys), rs1816286194, gnomAD 9-6250502-C-T, CADD 3.99
- P41A (p.Pro41Ala), TOPMed rs1399814792, gnomAD rs1399814792, AlphaMissense 0.11, MetaLR 0.06
- P41S (p.Pro41Ser), TOPMed rs1399814792, gnomAD rs1399814792, AlphaMissense 0.12, MetaLR 0.06
- P41H (p.Pro41His), gnomAD 9-6250504-C-A, AlphaMissense 0.08, MetaLR 0.04
- P41P (p.Pro41Pro), rs191226236, gnomAD 9-6250505-C-T, CADD 0.51
- M42I (p.Met42Ile), gnomAD rs1409344077, AlphaMissense 0.14, MetaLR 0.04
- M42R (p.Met42Arg), gnomAD rs202160657
- M42T (p.Met42Thr), gnomAD rs202160657, AlphaMissense 0.10, MetaLR 0.09
- M42V (p.Met42Val), ExAC rs748625551, TOPMed rs748625551, gnomAD rs748625551, AlphaMissense 0.05, MetaLR 0.04
- M42C (p.Met42Cys), rs758191115, gnomAD 9-6250501-GC-G, CADD 16.70
- M42K (p.Met42Lys), gnomAD 9-6250507-T-A, AlphaMissense 0.12, MetaLR 0.09
- Y43H (p.Tyr43His), gnomAD 9-6250509-T-C, AlphaMissense 0.28, MetaLR 0.29
- Y43C (p.Tyr43Cys), gnomAD 9-6250510-A-G, AlphaMissense 0.17, MetaLR 0.27
- Y43* (p.Tyr43Ter), gnomAD 9-6250511-C-G, CADD 32.00
- Y43Y (p.Tyr43Tyr), rs772355150, gnomAD 9-6250511-C-T, CADD 0.87
- F44Y (p.Phe44Tyr), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10119, Variant assessed as somatic; moderate impact.
- F44S (p.Phe44Ser), gnomAD 9-6250513-T-C, AlphaMissense 0.13, MetaLR 0.09
- F44F (p.Phe44Phe), gnomAD 9-6250514-T-C, CADD 0.65
- M45K (p.Met45Lys), ExAC rs773578845, gnomAD rs773578845, AlphaMissense 0.41, MetaLR 0.13
- M45R (p.Met45Arg), ExAC rs773578845, gnomAD rs773578845
- M45L (p.Met45Leu), gnomAD 9-6250515-A-C, AlphaMissense 0.32, MetaLR 0.11
- K46M (p.Lys46Met), gnomAD 9-6250519-A-T, AlphaMissense 0.22, MetaLR 0.08
- L47F (p.Leu47Phe), Ensembl rs1816287913
- L47V (p.Leu47Val), gnomAD 9-6250521-C-G, AlphaMissense 0.33, MetaLR 0.28
- L47L (p.Leu47Leu), gnomAD 9-6250523-C-G, CADD 0.48
- R48C (p.Arg48Cys), rs200883197, ClinGen CA4978749, ClinVar RCV004253947, ESP rs200883197, AlphaMissense 0.25, MetaLR 0.19, Uncertain significance, not specified
- R48H (p.Arg48His), rs770611056, NCI-TCGA Cosmic COSV6734, cosmic curated COSV67343, ExAC rs770611056, AlphaMissense 0.27, MetaLR 0.26, Variant assessed as somatic; moderate impact.
- R48L (p.Arg48Leu), gnomAD 9-6250525-G-T, AlphaMissense 0.51, MetaLR 0.30
- R48R (p.Arg48Arg), rs377757346, gnomAD 9-6250526-C-T, CADD 6.22
- S49C (p.Ser49Cys), ExAC rs764666831, TOPMed rs764666831, gnomAD rs764666831, AlphaMissense 0.26, MetaLR 0.34
- S49T (p.Ser49Thr), ExAC rs759104347, gnomAD rs759104347, AlphaMissense 0.25, MetaLR 0.28
- G50A (p.Gly50Ala), gnomAD rs1816289184, AlphaMissense 0.44, MetaLR 0.35
- G50C (p.Gly50Cys), gnomAD 9-6250530-G-T, AlphaMissense 0.51, MetaLR 0.34
- G50R (p.Gly50Arg), gnomAD 9-6250530-G-C, AlphaMissense 0.57, MetaLR 0.24
- G50D (p.Gly50Asp), gnomAD 9-6250531-G-A, AlphaMissense 0.57, MetaLR 0.35
- G50G (p.Gly50Gly), rs375298218, gnomAD 9-6250532-C-A, CADD 1.00
- L51L (p.Leu51Leu), gnomAD 9-6250535-T-G, CADD 2.69
- M52I (p.Met52Ile), NCI-TCGA Cosmic COSV6734, cosmic curated COSV67342, ExAC rs763815252, gnomAD rs763815252, AlphaMissense 0.16, MetaLR 0.03, Variant assessed as somatic; moderate impact.
- M52L (p.Met52Leu), ExAC rs762904713, TOPMed rs762904713, gnomAD rs762904713, AlphaMissense 0.12, MetaLR 0.04
- M52V (p.Met52Val), ExAC rs762904713, TOPMed rs762904713, gnomAD rs762904713, AlphaMissense 0.08, MetaLR 0.06
- I53T (p.Ile53Thr), gnomAD rs1816290100, AlphaMissense 0.50, MetaLR 0.17
- K54R (p.Lys54Arg), ExAC rs751415058, TOPMed rs751415058, gnomAD rs751415058, AlphaMissense 0.09, MetaLR 0.05
- K54T (p.Lys54Thr), ExAC rs751415058, TOPMed rs751415058, gnomAD rs751415058, AlphaMissense 0.20, MetaLR 0.08
- K55R (p.Lys55Arg), rs138513976, ClinGen CA4978759, ClinVar RCV004191967, 1000Genomes rs138513976, AlphaMissense 0.12, MetaLR 0.12, Uncertain significance, not specified
- K55K (p.Lys55Lys), rs1816290725, gnomAD 9-6250547-G-A, CADD 1.80
- E56G (p.Glu56Gly), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10119, Variant assessed as somatic; moderate impact.
- E56K (p.Glu56Lys), gnomAD 9-6250548-G-A, AlphaMissense 0.10, MetaLR 0.05
- E56A (p.Glu56Ala), gnomAD 9-6250549-A-C, AlphaMissense 0.14, MetaLR 0.09
- E56E (p.Glu56Glu), rs754058593, gnomAD 9-6250550-G-A, CADD 1.07
- A57S (p.Ala57Ser), 1000Genomes rs183839589, TOPMed rs183839589, gnomAD rs183839589, AlphaMissense 0.12, MetaLR 0.07
- A57T (p.Ala57Thr), 1000Genomes rs183839589, TOPMed rs183839589, gnomAD rs183839589, AlphaMissense 0.10, MetaLR 0.06, Uncertain significance, not specified
- A57V (p.Ala57Val), gnomAD 9-6250552-C-T, AlphaMissense 0.16, MetaLR 0.06
- A57A (p.Ala57Ala), rs755118322, gnomAD 9-6250553-C-T, CADD 9.18
- C58F (p.Cys58Phe), gnomAD rs1306183928, AlphaMissense 0.17, MetaLR 0.10
- C58G (p.Cys58Gly), ExAC rs779013655, gnomAD rs779013655, AlphaMissense 0.13, MetaLR 0.11
- C58L (p.Cys58Leu), rs1169854342, gnomAD 9-6250551-G-GC, CADD 20.20
- C58Y (p.Cys58Tyr), gnomAD 9-6250555-G-A, AlphaMissense 0.18, MetaLR 0.09
- C58S (p.Cys58Ser), gnomAD 9-6250555-G-C, AlphaMissense 0.20, MetaLR 0.05
- C58C (p.Cys58Cys), gnomAD 9-6250556-T-C, CADD 7.55
- Y59C (p.Tyr59Cys), Ensembl rs1352489990
- Y59Y (p.Tyr59Tyr), rs1347479977, gnomAD 9-6250559-C-T, CADD 4.77
- F60C (p.Phe60Cys), gnomAD rs1387802000, AlphaMissense 0.20, MetaLR 0.30
- F60L (p.Phe60Leu), ExAC rs748626570, TOPMed rs748626570, gnomAD rs748626570, AlphaMissense 0.64, MetaLR 0.23
- p.Phe60 Arg61insSerMetIleLysLysG, rs1816289529, gnomAD 9-6250534-T-TTATG, CADD 2.92
- F60S (p.Phe60Ser), gnomAD 9-6250561-T-C, AlphaMissense 0.23, MetaLR 0.30
- R61K (p.Arg61Lys), gnomAD rs1329680063, AlphaMissense 0.11, MetaLR 0.10
- R61T (p.Arg61Thr), gnomAD 9-6250564-G-C, AlphaMissense 0.19, MetaLR 0.20
- R61R (p.Arg61Arg), gnomAD 9-6250565-G-A, CADD 6.82
- R62G (p.Arg62Gly), TOPMed rs1816292972
- R62S (p.Arg62Ser), gnomAD 9-6250568-A-C, AlphaMissense 0.27, MetaLR 0.07
- E63Q (p.Glu63Gln), gnomAD 9-6250569-G-C, AlphaMissense 0.17, MetaLR 0.19
- T64S (p.Thr64Ser), TOPMed rs1816293139
- T64I (p.Thr64Ile), gnomAD 9-6250573-C-T, AlphaMissense 0.13, MetaLR 0.06
- T64T (p.Thr64Thr), rs772684214, gnomAD 9-6250574-C-G, CADD 0.68
- T65I (p.Thr65Ile), ExAC rs778113447, gnomAD rs778113447, AlphaMissense 0.19, MetaLR 0.17
- K66R (p.Lys66Arg), gnomAD rs1340940380, AlphaMissense 0.08, MetaLR 0.11
- R67K (p.Arg67Lys), Ensembl rs778596858
- P68H (p.Pro68His), TOPMed rs1816294095
- P68L (p.Pro68Leu), TOPMed rs1816294095
- P68S (p.Pro68Ser), TOPMed rs975363841
- S69L (p.Ser69Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S69S (p.Ser69Ser), rs1202607931, gnomAD 9-6250589-A-G, CADD 4.37
- L70* (p.Leu70Ter), gnomAD 9-6250588-CA-C, CADD 19.10
Public IL33 analysis runs
- IL33 analysis run — IL33 (583 variants) — completed 2026-08-21